ENDYMION2 · TAK-935-3003
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase III prospective, open-label, multicenter extension study to evaluate the long-term safety and tolerability of soticlestat as adjunctive treatment in patients with Dravet syndrome or Lennox–Gastaut syndrome (ENDYMION 2). EudraCT: 2021-002482-17
Sponsor: TAKEDA
Phase: III
Area: Epilepsy